This activity will highlight the growing challenges in HTx and explain the current HTx allocation policy, review ways to provide a more equitable distribution of organs to expand the donor pool, and discuss methods to improve quality of life and survival for HTx recipients.

This activity will identify predictive factors for these outcomes that may allow for earlier transplantation.

This activity will provide an overview of CRISPR, its challenges, ethical concerns, and the role it plays in developing therapies.

This activity will discuss novel therapies for acute and chronic GVHD that have shown promising results in early phase studies and compare them with currently available therapies.

This activity will discuss the monitoring, prevention, and management of long-term health conditions in childhood cancer survivors and strategies to optimize their long-term care.

This activity will explore trends in the incidence of cancer and review contributing factors that may lead to increasing the incidence rates of certain cancers among children, adolescents and adults. The ongoing negative impact of COVID-19 on cancer and future cancer care will also be discussed.

This activity will discuss the ethical challenges associated with liver-transplant allocation and the risks and benefits of liver transplant for recipients with fragility, alcoholic hepatitis, and advanced cancer.

This activity will discuss the mechanisms for COVID-19 pathogenesis, clinical manifestations and multiple-organ involvement, as well as the affiliated health inequities that exist.